Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario
Immunomodulatory and immunosuppressive therapy is needed in people with a chronic neuroinflammatory disease of the central nervous system such as multiple sclerosis (MS). Therefore, MS requires monitoring for and preventing against infectious diseases like SARS-CoV-2. Vaccination and anti-viral trea...
Main Authors: | Muriel Schraad, Stefan Runkel, Walter Hitzler, Maria Protopapa, Stefan Bittner, Timo Uphaus, Frauke Zipp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/12/3/296 |
Similar Items
-
Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisResearch in context
by: Muriel Schraad, et al.
Published: (2023-01-01) -
Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma
by: Katrin Pape, et al.
Published: (2023-11-01) -
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
by: Stanley Cohan, et al.
Published: (2020-07-01) -
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
by: Grace Lassiter, et al.
Published: (2020-12-01) -
COVID-19 Vaccination Coverage and Associated Factors in Patients with Multiple Sclerosis
by: Ignacio Hernández-García, et al.
Published: (2024-01-01)